BREAKING NEWS: Professor Klimas Has FDA Approval for MONOCLONAL ANTIBODY RESEARCH!
PROFESSOR KLIMAS HAS FDA APPROVAL FOR MONOCLONAL ANTIBODY RESEARCH!
BREAKING NEWS
BREAKING RESEARCH
Long Covid Researchers
Biomarkers
Certified CPD
Latest Research | Long Covid
Relief | Treatments
E23: Are Monoclonal Antibodies a Possible Treatment for Long COVID? ft Prof Nancy Kilmas
E23 Join Prof Nancy Klimas to discover groundbreaking insights into Long COVID treatments! Explore how monoclonal antibodies offer hope by targeting viral persistence and spike proteins. Learn from leading experts shaping the future of recovery and resilience.